← Back
$CCCC All transactions

C4 Therapeutics, Inc.

A

$ Value

$11K

Shares

4,259

Price

$3

Filed

Apr 3

Insider

Name

Anderson Kenneth Carl

Title

CIK

0001824862

Roles

Director

Transaction Details

Transaction Date

2026-04-01

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

68,230

Footnotes

These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. | The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026. | Shares held by the Kenneth C. Anderson 2021 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. | Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. | Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. | Shares held by the Kenneth C. Anderson Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. | Shares held by the Cynthia E. Anderson Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0001470831-26-000346

Form Type

4

Issuer CIK

0001662579

Anderson Kenneth Carl's History

Date Ticker Type Value
2026-04-01 CCCC A $11K
2026-01-02 CCCC A $11K
2025-10-01 CCCC A $12K
2025-07-01 CCCC A $12K
2025-06-18 CCCC A $0

Other Insiders at CCCC (90d)

Insider Bought Sold Last
REYNO LEONARD
Chief Medical Officer
2026-02-14
Hirsch Andrew
President & CEO
2026-02-15
GROGAN DONNA ROY 2026-04-01
Schick Kelly
Chief People Officer
2026-02-14
Boyle Scott N
Chief Business Officer
2026-02-14
Adams Kendra
Chief Financial Officer
2026-02-14
Mossler Mark
Chief Accounting Officer
2026-02-14
Mahaney Paige
Chief Scientific Officer
2026-02-14